medigraphic.com
Órgano Oficial del Instituto Nacional de Pediatría

2019, Number 4

<< Back Next >>

Acta Pediatr Mex 2019; 40 (4)

Infant with congenital leukemia and graft versus host disease

López-Hernández G, Olivas-Román LR, Salazar-Rosales HP, Corcuera-Delgado CT

Language: Spanish
References: 24
Page: 223-233
PDF size: 2059.44 Kb.


Text Extraction

No abstract.


REFERENCES

  1. Fajardo-Gutiérrez A, et al. Frecuencia de neoplasias malignas en niños atendidos en hospitales del Distrito Federal. Estudio multicéntrico. Bol Med Hosp Infant Mex 1996;53 (2):58-66.

  2. Rivera-Luna R, et al. El niño de población abierta con cáncer en México. Consideraciones epidemiológicas. An Med (Mex) 2015;60(2):91-97.

  3. Palman J, et al. Neonatal acute lymphocytic leukaemia: an unusual presentation of a rare disease. BMJ Case Rep 2015. http://doi.org/10.1136/bcr-2015-210606.

  4. González-García NE, et al. Leucemia congénita aguda. Rev Cuba Pediatr 2011;83(1):193-199.

  5. Raimondi SC. 11q23 rearrangements in childhood acute lymphoblastic leukemia. Atlas Genet Cytogenet Oncol Haematol 2004;8(2):97-102.

  6. Hsiao YW, et al. Blueberry muffin baby with acute myeloid leukemia and spontaneous remission. Dermatol Sinica 2011;29(2):47-49. https://doi.org/10.1016/j. dsi.2011.01.005

  7. Priyadarshini Shrivastava J, et al. Congenital acute myeloid leukemia: A rare diagnostic enigma case report with review of literature. South Asian J Cancer 2016; 5(4): 212–213. http://doi.org/10.4103/2278-330X.195349

  8. Van der Linden MH, et al. Diagnosis and management of neonatal leukaemia. Semin Fetal Neonatal Med 2012;17(4):192-195. https://doi.org/10.1016/j. siny.2012.03.003

  9. Pieters R, et al. A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant- 99): an observational study and a multicentre randomised trial. Lancet. 2007;370(9583):240-250. https:// doi.org/10.1016/S0140-6736(07)61126-X

  10. Schiller GJ. High-risk acute myelogenous leukemia: treatment today ... and tomorrow. Hematology Am Soc Hematol Educ Program 2013;2013:201-8. https://doi.org/10.1182/ asheducation-2013.1.201

  11. Hong KT, et al. Peri-engraftment syndrome in allogeneic hematopoietic SCT. Bone Marrow Transplant 2013;48(4):523-8. https://doi.org/10.1038/bmt.2012.171

  12. Lee YH, et al. Pre-engraftment syndrome: clinical significance and pathophysiology. Blood Res 2016;51(3):152-154. https://doi.org/10.5045/br.2016.51.3.152

  13. Spitzer TR. Engraftment syndrome following hematopoietic stem cell transplantation. Bone Marrow Transplant 2001;27:893-898. https://doi.org/10.1038/sj.bmt.1703015

  14. Takami A. Hematopoietic stem cell transplantation for acute myeloid leukemia. Int J Hematol. 2018;107(5):513-518. https://doi.org/10.1007/s12185-018-2412-8

  15. Martin PJ, et al. Increasingly frequent diagnosis of acute graft versus-host disease after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 2004;10:320- 327. https://doi.org/10.1016/j.bbmt.2003.12.304

  16. Eapen M, et al. Higher mortality after allogeneic peripheralblood transplantation compared with bone marrow in children and adolescents: The Histocompatibility and Alternate Stem Cell Source Working Committee of the International Bone Marrow Transplant Registry. J Clin Oncol 2004;22:4872- 4880. https://doi.org/10.1200/JCO.2004.02.189

  17. Longnecker DS, et al. Relationship of age to prevalence of focal acinar cell dysplasia in the human pancreas. J Natl Cancer Inst 1980;65(1):63-6.

  18. Saliba RM, et al. Prognostic value of response after upfront therapy for acute GVHD. Bone Marrow Transplant 2012;47(1): 125–131. https://doi.org/10.1038/bmt.2011.41

  19. Myerson D, et al.Graft-versus-Host Disease of the Gut: A Histologic Activity Grading System and Validation. Biol Blood Marrow Transplant. 2017;23:1573-1579. https://doi. org/10.1016/j.bbmt.2017.05.017

  20. Narkhede M, et al. The association of histologic grade with acute graft-versus-host disease response and outcomes; Am J Hematol. 2017;92:683-688. https://doi.org/10.1002/ ajh.24749

  21. Lerner KG, et al. Histopathology of graft-vs.-host reaction (GvHR) in human recipients of marrow from HL-A-matched sibling donors. Transplant Proc 1974; 6:367-371.

  22. Banff schema for grading liver allograft rejection: an international consensus document. Hepatology (Baltimore, Md). 1997;25(3):658-63. https://doi.org/10.1002/ hep.510250328

  23. Washington K, et al. Pathology of graft-versus-host disease in the gastrointestinal tract. Hum Pathol 2009;40(7):909-17. https://doi.org/10.1016/j.humpath.2009.04.001

  24. Gonzalez RSet al. Challenges in diagnosing medication resins in surgical pathology specimens: a crystal-clear review guide. Arch Pathol Lab Med 2017;141(9):1276-1282. https://doi. org/10.5858/arpa.2016-0587-RA




2020     |     www.medigraphic.com